Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

Leveraging Tech to Apply New Biomedical Discoveries — featuring Lloyd Minor of S

S1 Ep4: Leveraging Tech to Apply New Biomedical Discoveries — featuring Lloyd Minor of Stanford Medicine

Dean

The Beat: AI's Impact on Healthcare Growth

Imagine a platform seamlessly integrating virtual, in-person, and home care through cutting-edge digital and AI technologies for a holistic healthcare experience In this episode, Ashok Chennuru, Global Chief Data and Insights Officer at Elevance Health shares insights on the strategies and initiatives at Elevance Health, the largest health insurer in the country. Ashok shares the mental map of Elevance Health&#39;s three businesses, highlighting the comprehensive portfolio of products and solutions they offer to serve over 119 million lives. He also delves into the strategic priorities for growth in each segment, shedding light on the use of digital platforms, data-driven insights, and the harnessing of AI to drive meaningful advances. Ashok emphasizes how AI has been incorporated into every function across the organization, including streamlining operations, predictive analytics, and enhancing consumer and provider experiences. Ashok provides insights into Elevance Health&#39;s engagement with the startup ecosystem, detailing the criteria for vendor partnerships and the focus on scalable opportunities that benefit not only Elevance Health but also the broader healthcare landscape. Join us as we explore the intersection of healthcare, technology, and responsible AI with Ashok Chennuru. About Ashok Chennuru:Ashok Chennuru serves as Global Chief Data &amp; Insights Officer and Interim Lead of Carelon Digital Platforms. Ashok oversees the responsibility of carrying out the vision of Carelon Digital Platforms and bringing to life digital solutions that enhance healthcare outcomes and accelerate growth by reimagining care delivery, operations, and consumer experiences. He uses data analytics to drive a digital-first approach across the company&#39;s artificial intelligence (AI), exponential technology, service experience, and innovation portfolios, as well as the commercialization efforts of digital capabilities for consumers, care providers, and the health ecosystem. Prior to his current role, Ashok served as Vice President of Enterprise Data and Analytics for Anthem, Inc. for 8 years, as Director of Enterprise Information Architecture at Wellpoint for 6 years, and as Enterprise Technologist at Liberty Mutual for 6 years. He has over two decades of industry experience, where he has played a critical role in driving innovation and growth. Prior to joining Elevance Health, Ashok led the Information Business Intelligence team at Liberty Mutual and focused on delivering analytics to key business areas like Actuarial &amp; Finance. Preceding Liberty Mutual, Ashok worked in software giants SAP and Oracle as a software development engineer focused on analytics products.Ashok holds a master’s degree (MS) in Computer Science from the University of Missouri and a BS in Computer Science and Engineering from Madurai University in India. <a href="https://www.ahip.org/people/ashok-chennuru" target="_blank">Source</a> Things You’ll Learn:<ul><li>Elevance Health utilizes AI for automation, analytics, and improving consumer and provider experiences. </li><li>By leveraging a robust data set from administrative claims, EMR data, and social and behavioral data, Elevance Health drives AI-driven insights for personalized care recommendations and closing care gaps.</li><li>Elevance Health emphasizes responsible AI, ensuring fairness, inclusivity, robustness, security, traceability, and accountability in its AI practices. </li><li>The core priority of using digital platforms for health is to enhance the consumer experience, including AI-driven solutions like symptom checkers and virtual care.</li><li>The use of AI has already delivered tangible results, from personalized provider matches to streamlining prior authorizations, significantly improving consumer and provider experiences while driving operational efficiencies.</li></ul> Resources:<ul><li>Connect with and follow Ashok Chennuru on <a href="https://www.linkedin.com/in/ashok-chennuru-832711/" target="_blank">LinkedIn</a>.</li><li>Follow Accolade on <a href="https://www.linkedin.com/company/elevance-health/" target="_blank">LinkedIn</a> and visit their <a href="https://www.elevancehealth.com/" target="_blank">website</a>.</li></ul>

S1 E1: The Beat: AI's Impact on Healthcare Growth

Vice President, Global Chief Data & Insights Officer

Removing the Policy Barriers to Home-Based Care—featuring Krista Drobac

When Krista Drobac first started thinking about home-based health care, she assumed that the biggest barriers to adoption would be cultural. But she quickly learned that policy was the problem. And then came COVID-19. Regulations were loosened, and we were allowed to experiment with caring for patients at home. So, how do we convince policymakers to preserve the advances in home-based care made during the pandemic and change the rules for good? Krista serves as Partner at Sirona Strategies, Executive Director of the Alliance for Connected Care and Founder of <a href="https://movinghealthhome.org/" target="_blank">Moving Health Home</a>, a coalition working to change policy to enable the home to be a clinical site of care. Krista has 25 years of experience in federal and state government policy and public affairs, and she consults on Medicare, Medicaid, digital health, social determinants of health and new care models. On this episode of HLTH Matters, Krista joins hosts Dr. Jessica Shepherd, Dr. Gautam Gulati and Dr. Jordan Schlain to explore the innovations in hospital-at-home and SNF-at-home we achieved during the pandemic. Krista discusses who benefits most from home-based care (and who might want to opt out) and describes how providers can identify environmental risks when they’re in a patient’s home. Listen in to understand why Krista advocates for value-based reimbursement models and learn what you can do to help persuade legislators to embrace home-based care. Topics Covered<ul><li>The regulatory barriers to moving health care into the home prior to the pandemic</li><li>How Moving Health Home was launched to preserve the innovation and advances in home-based care made during COVID</li><li>Who benefits most from home-based care and who might want to opt out</li><li>What the hospital-at-home model looks like and how it took off during the pandemic</li><li>The regulatory challenges Moving Home Health faces in executing SNF-at-home</li><li>How home-based care allows providers to identify environmental risks</li><li>Why value-based care reimbursement models are more appropriate for home-based care than fee-for-service</li><li>How home-based care might improve a patient’s mental and emotional health</li><li>Why we need a large-scale demonstration of the benefits of home-based care to change policy</li><li>The power of patient voice in convincing legislatures and hospital systems to embrace home-based care</li><li>How we might incentivize or persuade Americans to choose healthy food</li><li>How the social determinants of health or SDOH are influenced by policy</li></ul>   Connect with Krista Drobac<a href="https://movinghealthhome.org/" target="_blank">Moving Health Home</a> Connect with Dr. Jessica Shepherd, Dr. Gautam Gulati &amp; Dr. Jordan Shlain<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/JShepherd_MD" target="_blank">Dr. Shepherd on Twitter</a><a href="https://www.linkedin.com/in/jessica-shepherd-md-mba-5ba9ab66/" target="_blank">Dr. Shepherd on LinkedIn</a><a href="https://twitter.com/drgautamgulati" target="_blank">Dr. Gulati on Twitter</a><a href="https://www.linkedin.com/in/gautamgulati" target="_blank">Dr. Gulati on LinkedIn</a><a href="https://twitter.com/DrShlain" target="_blank">Dr. Shlain on Twitter</a><a href="https://www.linkedin.com/in/drjordanshlain/" target="_blank">Dr. Shlain on LinkedIn</a> Resources<a href="https://essentialhospitals.org/" target="_blank">America’s Essential Hospitals</a><a href="https://www.cms.gov/files/document/covid-19-emergency-declaration-waivers.pdf" target="_blank">CMS COVID Waivers</a><a href="https://movinghealthhome.org/resource-items/studies/" target="_blank">Moving Health Home Studies</a><a href="https://frac.org/white-house-conference" target="_blank">White House Conference on Hunger, Nutrition and Health</a><a href="https://health.gov/healthypeople/priority-areas/social-determinants-health" target="_blank">Social Determinants of Health</a>

S3 Ep26: Removing the Policy Barriers to Home-Based Care—featuring Krista Drobac

Partner

The Future of Venture Capital in Healthcare—featuring Dr. Vineeta Agarwala

Several years ago, leading VC Marc Andreessen proposed the notion that innovation happens through a process of unbundling and rebundling.  Healthcare is no exception. Through the micro-specialization of companies, we’ve witnessed a great deal of unbundling in the industry. Now, we’ve begun the process of rebundling.  So, what does this mean for the future of healthcare tech? And how do venture investors leverage this idea to decide which digital health startups deserve funding? Dr. Vineeta Agarwala is General Partner at <a href="https://a16z.com/" target="_blank">Andreessen Horowitz</a>, where she leads investments for the a16z bio and health fund across digital health care delivery, biotech and life sciences tools and diagnostics.  Dr. Agarwala has a special interest in companies leveraging unique datasets to improve healthcare delivery, and she serves on several healthcare portfolio company boards, including Memorial Health, Thyme Care and Waymark. On this episode of HLTH Matters, Dr. Agarwala joins host Dr. Guatam Gulati to discuss what health payviders are doing to aggregate the best technology for specialty care and how we might integrate such specialized health tech into already complicated workflows. Dr. Agarwala shares her take on the successes and failures of digital health in the last decade, describing how healthcare tech has been transformative for certain patient populations and why she sees most remote connected wearables as a missed opportunity. Listen in to understand how the high bar for fundraising is changing the way a16z makes decisions and get Dr. Agarwala’s advice for aspiring founders in healthcare tech. Topics Covered <ul><li>How Dr. Agarwala thinks about the unbundling and rebundling of services in healthcare</li><li>What health payviders are doing to aggregate the best possible technology across large numbers of specialty care areas</li><li>How we might integrate specialized health tech into already complicated workflows (and why it’s such a challenge)</li><li>Dr. Agarwala’s take on patients, providers and payers as joint custodians of healthcare data</li><li>The pros and cons of imposing a government tax on corporations to access healthcare data</li><li>How digital health has been transformative for some small patient populations, health systems and provider practices</li><li>Why Dr. Agarwala sees remote connected wearables as a failure in the absence of intelligent care management</li><li>How the high bar for fundraising has changed the way a16z makes healthcare tech investment decisions</li><li>Why a16z is encouraging its portfolio companies to adopt a lean business model</li><li>Why now is a phenomenal time to start a company in the healthcare technology space</li><li>How Dr. Agarwala’s experience with her grandfather’s death informs her work at a16z</li></ul> Connect with Dr. Vineeta Agarwala<a href="https://a16z.com/author/vineeta-agarwala/" target="_blank">Dr. Agarwala at Andreessen Horowitz</a><a href="https://twitter.com/vintweeta" target="_blank">Dr. Agarwala on Twitter</a><a href="https://www.linkedin.com/in/vineeta-agarwala-md-phd-674a591/" target="_blank">Dr. Agarwala on LinkedIn</a> Connect with Dr. Guatam Gulati<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/drgautamgulati" target="_blank">Dr. Gulati on Twitter </a><a href="https://www.linkedin.com/in/gautamgulati" target="_blank">Dr. Gulati on LinkedIn </a> Resources <a href="https://a16z.com/author/julie-yoo/" target="_blank">Julie Yoo at Andreesen Horowitz</a><a href="https://www.thymecare.com/" target="_blank">Thyme Care</a>

S3 Ep2: The Future of Venture Capital in Healthcare—featuring Dr. Vineeta Agarwala

General Partner

Podcast

S1 Ep4: Leveraging Tech to Apply New Biomedical Discoveries — featuring Lloyd Minor of Stanford Medicine

FEATURING